Ole Schmitz

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

John Dormandy, B Charbonnel, D.J.A. Eckland et al. · The Lancet · 2005 · 4.1K citations · Full text

Diabetes Management, Cardiovascular Disease, Health Policy +10

Resequencing of 200 human exomes identifies an excess of low-frequency non-synonymous coding variants

Yingrui Li, Nicolas Vinckenbosch, Geng Tian et al. · Nature Genetics · 2010 · 315 citations

Genetic Analysis, Allelic Variant, Human Exomes Identifies +8

Meal and oral glucose tests for assessment of β-cell function: modeling analysis in normal subjects

Andrea Mari, Ole Schmitz, Amalia Gastaldelli et al. · American Journal of Physiology-Endocrinology and Metabolism · 2002 · 298 citations

Bedtime Administration of NN2211, a Long-Acting GLP-1 Derivative, Substantially Reduces Fasting and Postprandial Glycemia in Type 2 Diabetes

Claus Bogh Juhl, Malene Hollingdal, Jeppe Sturis et al. · Diabetes · 2002 · 266 citations · Full text

Studies of Association of Variants Near the <i>HHEX</i>, <i>CDKN2A/B</i>, and <i>IGF2BP2</i> Genes With Type 2 Diabetes and Impaired Insulin Release in 10,705 Danish Subjects

Niels Grarup, Chrisian S. Rose, Ehm A. Andersson et al. · Diabetes · 2007 · 258 citations · Full text